Is Revolution Medicines a Good Stock to Own?
Though it’s still quite early in the year, pharmaceutical startup…
Sell
39
PLYM Quote, Financials, Valuation and Earnings
Last price:
$21.89
Seasonality move
:
-3.18%
Day range:
$21.76 - $21.96
52-week range:
$12.70 - $22.74
Dividend yield:
4.39%
P/E ratio:
10.95x
P/S ratio:
5.12x
P/B ratio:
2.07x
Volume:
3.9M
Avg. volume:
1.5M
1-year change:
28.5%
Market cap:
$974.3M
Revenue:
$198.4M
EPS (TTM):
$2.00
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $109.9M | $140.6M | $183.5M | $199.8M | $198.4M | |
| Revenue Growth (YoY) | 45.9% | 28.01% | 30.52% | 8.89% | -0.75% | |
| Cost of Revenues | $94.6M | $118.3M | $151.9M | $155.4M | $147.4M | |
| Gross Profit | $15.3M | $22.3M | $31.6M | $44.4M | $50.9M | |
| Gross Profit Margin | 13.9% | 15.89% | 17.23% | 22.22% | 25.67% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -$433K | -$4.7M | -$563K | $22.6M | $139.5M | |
| Operating Expenses | $10.5M | $18M | $14.2M | $14.9M | $8.6M | |
| Operating Income | $4.8M | $4.3M | $17.4M | $29.5M | $42.3M | |
| Net Interest Expenses | $18.9M | $20M | $32.2M | $38.3M | $37.4M | |
| EBT. Incl. Unusual Items | -$14.5M | -$15.3M | -$17.1M | $13.8M | $144.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | $2.5M | |
| Net Income to Company | -$14.5M | -$15.3M | -$17.1M | $13.8M | $142.4M | |
| Minority Interest in Earnings | -$649K | -$259K | -$210K | $147K | $3M | |
| Net Income to Common Excl Extra Items | -$14.6M | -$15.5M | -$17.4M | $13.5M | $140.9M | |
| Basic EPS (Cont. Ops) | -$1.52 | -$0.94 | -$0.67 | $0.20 | $3.06 | |
| Diluted EPS (Cont. Ops) | -$1.52 | -$0.94 | -$0.67 | $0.20 | $3.06 | |
| Weighted Average Basic Share | $18.4M | $30.9M | $39.8M | $43.6M | $45M | |
| Weighted Average Diluted Share | $18.4M | $30.9M | $39.8M | $43.6M | $45M | |
| EBITDA | $61.2M | $74.9M | $112.8M | $122.4M | $128M | |
| EBIT | $4.8M | $4.3M | $17.4M | $29.5M | $42.3M | |
| Revenue (Reported) | $109.9M | $140.6M | $183.5M | $199.8M | $198.4M | |
| Operating Income (Reported) | $4.8M | $4.3M | $17.4M | $29.5M | $42.3M | |
| Operating Income (Adjusted) | $4.8M | $4.3M | $17.4M | $29.5M | $42.3M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $36M | $47.8M | $49.8M | $51.9M | $51.2M | |
| Revenue Growth (YoY) | 30.69% | 32.89% | 4.13% | 4.23% | -1.37% | |
| Cost of Revenues | $30.3M | $39.4M | $38.6M | $38.4M | $38.9M | |
| Gross Profit | $5.6M | $8.4M | $11.1M | $13.5M | $12.2M | |
| Gross Profit Margin | 15.64% | 17.65% | 22.37% | 26% | 23.94% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -$1.1M | -- | $12M | -$234K | -- | |
| Operating Expenses | $4.2M | $4.1M | $3.3M | $3.6M | $45.1M | |
| Operating Income | $1.4M | $4.4M | $7.8M | $9.9M | -$32.8M | |
| Net Interest Expenses | $4.9M | $9M | $9.5M | $10.4M | $9.4M | |
| EBT. Incl. Unusual Items | -$3.6M | -$4.6M | $10.4M | -$15.3M | -$52.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$3.6M | -$4.6M | $10.4M | -$15.3M | -$52.5M | |
| Minority Interest in Earnings | -$57K | -$55K | $114K | $256K | $1.9M | |
| Net Income to Common Excl Extra Items | -$3.7M | -$4.7M | $10.3M | -$15.4M | -$52.6M | |
| Basic EPS (Cont. Ops) | -$0.22 | -$0.19 | $0.17 | -$0.35 | -$1.23 | |
| Diluted EPS (Cont. Ops) | -$0.22 | -$0.19 | $0.17 | -$0.35 | -$1.23 | |
| Weighted Average Basic Share | $32.3M | $41.1M | $44.1M | $45M | $44.2M | |
| Weighted Average Diluted Share | $32.3M | $41.1M | $44.1M | $45M | $44.2M | |
| EBITDA | $19.7M | $29.2M | $30.7M | $30.9M | -$9.4M | |
| EBIT | $1.4M | $4.4M | $7.8M | $9.9M | -$32.8M | |
| Revenue (Reported) | $36M | $47.8M | $49.8M | $51.9M | $51.2M | |
| Operating Income (Reported) | $1.4M | $4.4M | $7.8M | $9.9M | -$32.8M | |
| Operating Income (Adjusted) | $1.4M | $4.4M | $7.8M | $9.9M | -$32.8M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $130.7M | $176.1M | $196.4M | $201.6M | $191.5M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $110.3M | $147M | $155.3M | $150.2M | $141.7M | |
| Gross Profit | $20.4M | $29.1M | $41.1M | $51.3M | $49.8M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -$1.9M | -$3.4M | $12M | $19.2M | -- | |
| Operating Expenses | $14.4M | $16.7M | $14.7M | $15.1M | $22M | |
| Operating Income | $6.1M | $12.4M | $26.4M | $36.2M | $27.9M | |
| Net Interest Expenses | $19.1M | $28.8M | $37.5M | $39.1M | $31.8M | |
| EBT. Incl. Unusual Items | -$13.2M | -$18.2M | $894K | $1.6M | $102.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | $2.2M | |
| Net Income to Company | -$13.2M | -$18.2M | $894K | $1.6M | $100.1M | |
| Minority Interest in Earnings | -$258K | -$236K | $6K | $439K | $7.3M | |
| Net Income to Common Excl Extra Items | -$13.3M | -$18.5M | $579K | $1.3M | $98.6M | |
| Basic EPS (Cont. Ops) | -$0.95 | -$0.81 | -$0.12 | $0.02 | $2.00 | |
| Diluted EPS (Cont. Ops) | -$0.95 | -$0.81 | -$0.12 | $0.02 | $2.00 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $71.9M | $103.8M | $120M | $123.7M | $111.5M | |
| EBIT | $6.1M | $12.4M | $26.4M | $36.2M | $27.9M | |
| Revenue (Reported) | $130.7M | $176.1M | $196.4M | $201.6M | $191.5M | |
| Operating Income (Reported) | $6.1M | $12.4M | $26.4M | $36.2M | $27.9M | |
| Operating Income (Adjusted) | $6.1M | $12.4M | $26.4M | $36.2M | $27.9M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $100.7M | $136.2M | $149.1M | $150.8M | $143.9M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $85.4M | $114.1M | $117.5M | $112.3M | $106.5M | |
| Gross Profit | $15.4M | $22.1M | $31.6M | $38.5M | $37.4M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -$1.9M | -$563K | $12M | $8.6M | -$14.6M | |
| Operating Expenses | $11.4M | $10M | $10.6M | $10.8M | $38.8M | |
| Operating Income | $4M | $12.1M | $21M | $27.6M | -$1.4M | |
| Net Interest Expenses | $14.5M | $23.3M | $28.6M | $29.4M | $23.7M | |
| EBT. Incl. Unusual Items | -$10.6M | -$13.6M | $4.4M | -$7.7M | -$50.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -$327K | |
| Net Income to Company | -$10.6M | -$13.6M | $4.4M | -$7.7M | -$50M | |
| Minority Interest in Earnings | -$193K | -$170K | $46K | $338K | $4.6M | |
| Net Income to Common Excl Extra Items | -$10.8M | -$13.8M | $4.2M | -$8M | -$50.3M | |
| Basic EPS (Cont. Ops) | -$0.71 | -$0.57 | -$0.02 | -$0.19 | -$1.24 | |
| Diluted EPS (Cont. Ops) | -$0.71 | -$0.57 | -$0.02 | -$0.19 | -$1.24 | |
| Weighted Average Basic Share | $88.9M | $116.5M | $129.3M | $134.9M | $134.2M | |
| Weighted Average Diluted Share | $88.9M | $116.5M | $129.4M | $135M | $134.2M | |
| EBITDA | $54.9M | $83.8M | $91.1M | $92.4M | $61.2M | |
| EBIT | $4M | $12.1M | $21M | $27.6M | -$1.4M | |
| Revenue (Reported) | $100.7M | $136.2M | $149.1M | $150.8M | $143.9M | |
| Operating Income (Reported) | $4M | $12.1M | $21M | $27.6M | -$1.4M | |
| Operating Income (Adjusted) | $4M | $12.1M | $21M | $27.6M | -$1.4M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $32.1M | $43.4M | $31.2M | $26.2M | $43.6M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $32.1M | $43.4M | $31.2M | $26.2M | $43.6M | |
| Property Plant And Equipment | $7.2M | $6.6M | $5.7M | $4.8M | $4.2M | |
| Long-Term Investments | $6.7M | $5.8M | $30.1M | $21.7M | $83.8M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | $66.1M | $75.9M | $70.7M | $51.5M | $41.7M | |
| Other Long-Term Assets | $27M | $33.9M | $39.1M | $42.7M | $42.6M | |
| Total Assets | $920.3M | $1.3B | $1.5B | $1.4B | $1.4B | |
| Accounts Payable | $49.3M | $66.9M | $72.6M | $73.9M | $83.8M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $5.4M | $6.2M | $116.6M | $23.2M | $3.4M | |
| Long-Term Debt | $534.9M | $702M | $815.6M | $861.2M | $651.6M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $581.1M | $767.3M | $998.1M | $953.7M | $781.3M | |
| Common Stock | $253K | $361K | $428K | $452K | $454K | |
| Other Common Equity Adj | -- | -- | $29.7M | $20.2M | $17.5M | |
| Common Equity | $198.8M | $355.8M | $471M | $483M | $579.5M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $4.8M | $4.8M | $5.4M | $5.2M | $7.6M | |
| Total Equity | $339.2M | $503.5M | $523.2M | $488.2M | $587.1M | |
| Total Liabilities and Equity | $920.3M | $1.3B | $1.5B | $1.4B | $1.4B | |
| Cash and Short Terms | $32.1M | $43.4M | $31.2M | $26.2M | $43.6M | |
| Total Debt | $540.3M | $708.2M | $932.4M | $884.4M | $655M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $78.9M | $36.3M | $30.3M | $33.6M | $42M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $78.9M | $36.3M | $30.3M | $233.1M | $42M | |
| Property Plant And Equipment | $6.8M | $5.9M | $5.1M | $4.4M | $3.7M | |
| Long-Term Investments | $6M | $32.4M | $34.1M | $22.4M | $47.9M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | $68.7M | $76.7M | $56.3M | $44.5M | -- | |
| Other Long-Term Assets | $35.9M | $36.6M | $39.6M | $49.3M | -- | |
| Total Assets | $1.1B | $1.5B | $1.5B | $1.5B | $1.6B | |
| Accounts Payable | $61.1M | $74.7M | $75.1M | $83.4M | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $39K | $39K | $39K | $68M | $59.2M | |
| Long-Term Debt | $603.9M | $924.5M | $905.4M | $833.8M | $798M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $656.9M | $992.2M | $974.5M | $1.1B | $1B | |
| Common Stock | $343K | $428K | $452K | $454K | $446K | |
| Other Common Equity Adj | -- | $32M | $33.7M | $12M | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -$15.9M | -$48.8M | -- | -- | |
| Minority Interest, Total | $4.7M | $5.6M | $5.4M | $5.2M | $82.9M | |
| Total Equity | $465.5M | $539M | $502M | $441.6M | $553M | |
| Total Liabilities and Equity | $1.1B | $1.5B | $1.5B | $1.5B | $1.6B | |
| Cash and Short Terms | $78.9M | $36.3M | $30.3M | $33.6M | $42M | |
| Total Debt | $603.9M | $924.6M | $905.5M | $833.9M | $857.2M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$14.5M | -$15.3M | -$17.1M | $13.8M | $142.4M | |
| Depreciation & Amoritzation | $56.4M | $70.6M | $95.3M | $92.9M | $85.7M | |
| Stock-Based Compensation | $1.4M | $1.6M | $2.6M | $3M | $4.2M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $41.7M | $57.9M | $72.2M | $81.9M | $96.1M | |
| Capital Expenditures | $6.1M | $25.3M | $55.5M | $34.8M | $24.2M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$259.1M | -$356.1M | -$252.4M | -$79K | $87.5M | |
| Dividends Paid (Ex Special Dividend) | $25.7M | $31.5M | $40M | $41.9M | $43.6M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $327.5M | $339M | $363M | $149.4M | $137M | |
| Long-Term Debt Repaid | -$206.6M | -$208.4M | -$194.7M | -$194.8M | -$307.3M | |
| Repurchase of Common Stock | $416K | $12K | $16.7M | $48.9M | $540K | |
| Other Financing Activities | -$2.9M | -$1.7M | -$1.8M | -$83K | $48.3M | |
| Cash From Financing | $227M | $309.5M | $168M | -$86.8M | -$166.1M | |
| Beginning Cash (CF) | $32.1M | $43.4M | $31.2M | $26.2M | $43.6M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $9.7M | $11.3M | -$12.2M | -$5M | $17.4M | |
| Ending Cash (CF) | $41.7M | $54.7M | $19.1M | $21.2M | $61.1M | |
| Levered Free Cash Flow | $35.7M | $32.6M | $16.7M | $47.1M | $71.8M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$3.6M | -$4.6M | $10.4M | -$15.3M | -$52.5M | |
| Depreciation & Amoritzation | $18.3M | $24.9M | $22.9M | $21M | $23.4M | |
| Stock-Based Compensation | $340K | $518K | $827K | $1.1M | $1.4M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $7.9M | $23.2M | $23.8M | $17.6M | $20M | |
| Capital Expenditures | $7.9M | $22.2M | $8M | $7.2M | $6.4M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$98.3M | -$39M | $10.2M | -$87.4M | -$6.9M | |
| Dividends Paid (Ex Special Dividend) | $8.3M | $10.2M | $10.5M | $11M | $11.8M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $159M | $42M | $17.5M | $133M | -- | |
| Long-Term Debt Repaid | -$78.4M | -$16.5M | -$48.7M | -$111.2M | -- | |
| Repurchase of Common Stock | -- | $15.9M | $48.8M | $207K | $3.7M | |
| Other Financing Activities | -$1.7M | -$108K | -- | $56.7M | -- | |
| Cash From Financing | $140M | $16M | -$42.2M | $67.2M | -$8.6M | |
| Beginning Cash (CF) | $78.9M | $36.3M | $30.3M | $33.6M | $42M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $49.6M | $187K | -$8.2M | -$2.6M | $4.5M | |
| Ending Cash (CF) | $128.6M | $36.4M | $22M | $31M | $46.5M | |
| Levered Free Cash Flow | $18K | $970K | $15.7M | $10.4M | $13.6M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$13.2M | -$18.2M | $894K | $1.6M | $100.1M | |
| Depreciation & Amoritzation | $65.8M | $91.4M | $93.7M | $87.5M | $83.6M | |
| Stock-Based Compensation | $1.6M | $1.8M | $3.2M | $4M | $5M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $45.5M | $82.2M | $76.6M | $72.7M | $101M | |
| Capital Expenditures | $17.1M | $49.4M | $42.3M | $24.7M | $25M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$293.8M | -$412.8M | -$24.1M | -$80M | -$111.5M | |
| Dividends Paid (Ex Special Dividend) | $29.2M | $38.5M | $42.1M | $42.6M | $46.4M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $391M | $491M | $37.5M | $254.9M | -- | |
| Long-Term Debt Repaid | -$227.3M | -$256.5M | -$53.9M | -$257.8M | -- | |
| Repurchase of Common Stock | $428K | $16.3M | $49.3M | $536K | $16.8M | |
| Other Financing Activities | -- | -$1.8M | -$55K | -- | -- | |
| Cash From Financing | $297.6M | $287.9M | -$58.5M | $10.6M | $18.9M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $49.3M | -$42.7M | -$6M | $3.3M | $8.4M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $28.4M | $32.9M | $34.3M | $48M | $76M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$10.6M | -$13.6M | $4.4M | -$7.7M | -$50M | |
| Depreciation & Amoritzation | $51M | $71.8M | $70.1M | $64.7M | $62.6M | |
| Stock-Based Compensation | $1.2M | $1.5M | $2.1M | $3.1M | $3.9M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $34.5M | $58.9M | $63.3M | $54M | $59M | |
| Capital Expenditures | $15.6M | $39.7M | $26.5M | $16.5M | $17.3M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$179.8M | -$236.6M | -$8.3M | -$88.2M | -$287.2M | |
| Dividends Paid (Ex Special Dividend) | $22.5M | $29.5M | $31.6M | $32.3M | $35.1M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $201M | $353M | $27.5M | $133M | $269.2M | |
| Long-Term Debt Repaid | -$145M | -$193.1M | -$52.4M | -$115.4M | -$76.6M | |
| Repurchase of Common Stock | $12K | $16.3M | $48.9M | $517K | $16.8M | |
| Other Financing Activities | -$1.7M | -$1.8M | -$27K | $56.7M | $78.9M | |
| Cash From Financing | $192.1M | $170.6M | -$55.9M | $41.5M | $226.5M | |
| Beginning Cash (CF) | $136.4M | $114.6M | $107.2M | $96.9M | $123M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $46.9M | -$7.1M | -$941K | $7.4M | -$1.7M | |
| Ending Cash (CF) | $183.3M | $107.5M | $106.3M | $104.3M | $121.3M | |
| Levered Free Cash Flow | $18.9M | $19.2M | $36.7M | $37.5M | $41.7M | |
Get PLYM Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
PLYM
Sector
P/E ratio
10.95x
17.59x
PEG ratio
0.00x
0.05x
P/B ratio
2.07x
0.83x
Price / LTM sales
5.12x
3.20x
Growth Metrics
PLYM
Sector
Revenue growth
-1.37%
3.09%
Earnings growth
-253.87%
4.98%
Revenue (5-year growth)
21.38%
2.86%
Earnings forecast
-$0.18
$0.14
Profitability
PLYM
Sector
Profitability FY 2024
$50.9M
$153.7M
Return on invested capital
7.36%
2.03%
Return on assets
6.64%
1.81%
Return on equity
17.72%
3.5%
Earnings Date
Last Earnings Date
Nov
10
Next Earnings Date
Feb
25
Estimated Next Earnings Date
Feb
9
Balance Sheet
PLYM
Sector
Total cash
$42M
$73.7M
Short term investments
--
$11.9M
Total assets
$1.4B
$3.2B
Long term debt
$857.2M
$349.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Has Vistra Stock Gone Up?
Integrated power generation business Vistra (NYSE:VST) surprised investors recently when…
Why Is Amkor Stock Up So Much?
Semiconductor packaging and testing major Amkor (NASDAQ:AMKR) has started 2026…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 64x
Buy
63
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Sell
50
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
80
BNR alert for Jan 16
Burning Rock Biotech Ltd. [BNR] is down 2.25% over the past day.
Buy
90
PEN alert for Jan 16
Penumbra, Inc. [PEN] is up 0.23% over the past day.
Buy
100
TLN alert for Jan 16
Talen Energy Corp. [TLN] is down 5.89% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
